
Sign up to save your podcasts
Or
Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.21.25924
Intracranial deposition of gadolinium after contrast-enhanced MRI is an emerging area of concern with much still to be learned. Kalen Riley, MD, MBA discusses a new article that proposes a dose-reduction strategy that takes advantage of relatively higher T1 relaxivity of one macrocyclic agent compared to another while still striving to maintain an adequate imaging examination.
4.5
4343 ratings
Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.21.25924
Intracranial deposition of gadolinium after contrast-enhanced MRI is an emerging area of concern with much still to be learned. Kalen Riley, MD, MBA discusses a new article that proposes a dose-reduction strategy that takes advantage of relatively higher T1 relaxivity of one macrocyclic agent compared to another while still striving to maintain an adequate imaging examination.
11,185 Listeners
3,179 Listeners
88 Listeners
27 Listeners
21,892 Listeners
494 Listeners
43,337 Listeners
2,423 Listeners
29 Listeners
8,004 Listeners
134 Listeners
26,924 Listeners
218 Listeners
205 Listeners
28,581 Listeners